Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap | 8.74M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -4.56M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
Sales | 148.98k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -6.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -36.00% |
Recommedations | - | Quick Ratio | 0.08 | Shares Outstanding | 131.85M | 52W Low Chg | 22.00% |
Insider Own | 34.93% | ROA | -37.06% | Shares Float | 84.80M | Beta | 0.55 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.07 |
Gross Margin | 73.48% | Profit Margin | - | Avg. Volume | 3,705 | Target Price | - |
Oper. Margin | -2,248.93% | Earnings Date | May 23 | Volume | 100 | Change | 0.00% |
About KANE BIOTECH INC
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; and animal and human wound care solutions under the DispersinB name. It also offers scalp care products under the DermaKB brand name; and wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, Aledex, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
KANE BIOTECH INC News